SFMG Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

SFMG Wealth Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,493	Closed	-$214K	–	300
2021 Q4	$214K	Hold	3,493	–	–	0.02%	259
2021 Q3	$261K	Buy	3,493 +99	+3%	+$8.31K	0.03%	211
2021 Q2	$314K	Buy	+3,394	New	+$289K	0.03%	189
2021 Q1	–	Sell	-2,249	Closed	-$210K	–	242
2020 Q4	$210K	Buy	+2,249	New	+$179K	0.03%	205

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

SFMG Wealth Advisors's ARKG Position: Q1 2022 in Review

SFMG Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 3,493 shares — an estimated $214K sold.

SFMG Wealth Advisors first reported a position in ARKG in Q4 2020 and held it in 4 quarters. The position peaked at $314K in Q2 2021. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

SFMG Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
SFMG Wealth Advisors sold 3,493 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $214K.
SFMG Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 4 quarters.
SFMG Wealth Advisors's ARK Genomic Revolution ETF position peaked at $314K in Q2 2021.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on SFMG Wealth Advisors's 13F filing for Q1 2022, filed 21 Apr 2022.